Barrera, M.D.; Callahan, V.; Akhrymuk, I.; Bhalla, N.; Zhou, W.; Campbell, C.; Narayanan, A.; Kehn-Hall, K.
Proteomic Discovery of VEEV E2-Host Partner Interactions Identifies GRP78 Inhibitor HA15 as a Potential Therapeutic for Alphavirus Infections. Pathogens 2021, 10, 283.
https://doi.org/10.3390/pathogens10030283
AMA Style
Barrera MD, Callahan V, Akhrymuk I, Bhalla N, Zhou W, Campbell C, Narayanan A, Kehn-Hall K.
Proteomic Discovery of VEEV E2-Host Partner Interactions Identifies GRP78 Inhibitor HA15 as a Potential Therapeutic for Alphavirus Infections. Pathogens. 2021; 10(3):283.
https://doi.org/10.3390/pathogens10030283
Chicago/Turabian Style
Barrera, Michael D., Victoria Callahan, Ivan Akhrymuk, Nishank Bhalla, Weidong Zhou, Catherine Campbell, Aarthi Narayanan, and Kylene Kehn-Hall.
2021. "Proteomic Discovery of VEEV E2-Host Partner Interactions Identifies GRP78 Inhibitor HA15 as a Potential Therapeutic for Alphavirus Infections" Pathogens 10, no. 3: 283.
https://doi.org/10.3390/pathogens10030283
APA Style
Barrera, M. D., Callahan, V., Akhrymuk, I., Bhalla, N., Zhou, W., Campbell, C., Narayanan, A., & Kehn-Hall, K.
(2021). Proteomic Discovery of VEEV E2-Host Partner Interactions Identifies GRP78 Inhibitor HA15 as a Potential Therapeutic for Alphavirus Infections. Pathogens, 10(3), 283.
https://doi.org/10.3390/pathogens10030283